Revvity, Inc. (RVTY) Presents at 2026 Global Healthcare Conference Transcript

SA Transcripts 162.21K Followers Follow Revvity, Inc. ( RVTY ) 2026 Global Healthcare Conference September 15, 2026 9:05 AM EDT Company Participants Stephen Willoughby - Senior VP of Investor Relations & Head of ESG Conference Call Participants Robert Bamberger - Robert W. Baird & Co. Incorporated, Research Division Presentation Robert Bamberger Robert W. Baird & Co. Incorporated, Research Division All right. Great. Good morning, everyone. My name is Robbie Bamberger, Senior Research Analyst covering Life Sciences and Diagnostics. I'm very pleased to be joined this morning by Steve Willoughby, Senior VP of Investor Relations at Revvity. Steve thanks for making the trip. Stephen Willoughby Senior VP of Investor Relations & Head of ESG Yes. Question-and-Answer Session Robert Bamberger Robert W. Baird & Co. Incorporated, Research Division I guess before we get into segment specifics on the company, would you just mind giving us a quick breakdown, snapshot of the company coming off of Q2 earnings print. What went right in the quarter? And anything you'd like to just point out to investors about the quarter in general? Stephen Willoughby Senior VP of Investor Relations & Head of ESG Sure. So maybe thanks for having me, first of all. Maybe just a quick overview of the company for those who are not familiar. Revvity a couple of years ago was previously known as PerkinElmer. We divested 30% of the company, including the PerkinElmer brand name, rebranded as Revvity in the middle of 2023. Revvity today is in the life science tools and diagnostics industry. And what I'd like to say is what we do in life science tools and what we do in diagnostics is typically a little bit different than other publicly traded companies. So specialty diagnostics and then on the life science tools side, really focused in preclinical R&D, providing instruments, consumables, software that are used by academic and pharma biotech customers